Cargando…
Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication
IMPORTANCE: Misinformation about cannabis and opioid use disorder (OUD) may increase morbidity and mortality if it leads individuals with OUD to forego evidence-based treatment. It has not been systematically evaluated whether officially designating OUD as a qualifying condition for medical cannabis...
Autores principales: | Shover, Chelsea L., Vest, Noel A., Chen, Derek, Stueber, Amanda, Falasinnu, Titilola O., Hah, Jennifer M., Kim, Jinhee, Mackey, Ian, Weber, Kenneth A., Ziadni, Maisa, Humphreys, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361653/ https://www.ncbi.nlm.nih.gov/pubmed/32662844 http://dx.doi.org/10.1001/jamanetworkopen.2020.10001 |
Ejemplares similares
-
Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance
por: Shover, Chelsea L., et al.
Publicado: (2020) -
Association between medical cannabis laws and opioid overdose mortality has reversed over time
por: Shover, Chelsea L., et al.
Publicado: (2019) -
Training and Practices of Cannabis Dispensary Staff
por: Haug, Nancy A., et al.
Publicado: (2016) -
Efficacy and mechanisms of a single-session behavioral medicine class among patients with chronic pain taking prescription opioids: study protocol for a randomized controlled trial
por: Ziadni, Maisa S., et al.
Publicado: (2020) -
Backgrounds and Trainings in Cannabis Therapeutics of Dispensary Personnel
por: Braun, Ilana M., et al.
Publicado: (2022)